Thomas Moriarty - 21 Feb 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP & General Counsel
Signature
/s/ Thomas M. Moriarty
Issuer symbol
CVS
Transactions as of
21 Feb 2022
Transactions value $
$0
Form type
4
Filing time
23 Feb 2022, 15:30:24 UTC
Previous filing
12 May 2021
Next filing
17 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Award $0 +573K +1161.84% $0.00 622K 21 Feb 2022 Direct F1
transaction CVS Common Stock Award $0 +215K +34.56% $0.00 837K 21 Feb 2022 Direct F2
holding CVS Common Stock 81.2K 21 Feb 2022 By GRAT
holding CVS Common Stock (restricted) 8.01K 21 Feb 2022 Direct
holding CVS Stock Unit 46.5K 21 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVS Stock Option 51.4K 21 Feb 2022 Common Stock 51.4K $102.26 Direct F3
holding CVS Stock Option 71.7K 21 Feb 2022 Common Stock 71.7K $104.82 Direct F4
holding CVS Stock Option 125K 21 Feb 2022 Common Stock 125K $78.05 Direct F5
holding CVS Stock Option 36.5K 21 Feb 2022 Common Stock 36.5K $62.21 Direct F6
holding CVS Stock Option 101K 21 Feb 2022 Common Stock 101K $54.19 Direct F7
holding CVS Stock Option 148K 21 Feb 2022 Common Stock 148K $58.34 Direct F8, F9
holding CVS Stock Option 155K 21 Feb 2022 Common Stock 155K $74.30 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on August 30, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022.
F2 Represents shares earned by the reporting person pursuant to PSUs that were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on June 5, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022.
F3 Option became exercisable in four equal annual installments, commencing 4/1/2016.
F4 Option became exercisable in four equal annual installments, commencing 4/1/2017.
F5 Option became exercisable in four equal annual installments, commencing 4/3/2018.
F6 Option became exercisable in four equal annual installments, commencing 4/1/2019.
F7 Option became exercisable in four equal annual installments, commencing 4/1/2020.
F8 The number of shares subject to the option were calculated using a 30-day average price.
F9 Option became exercisable in four equal annual installments, commencing 4/1/2021.
F10 Option becomes exercisable in four equal installments, commencing 4/1/2022.